NVOvsRDY
Novo-Nordisk A/SvsDr. Reddy's Laboratories Limited American Depositary Shares. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Novo-Nordisk A/S
$41.17
-13.82%
Dr. Reddy's Laboratories Limited American Depositary Shares
$13.67
-2.98%
60-day price, rebased to 100
Round-by-round
Valuation upside
+575.00% vs +7281.00% to DCF fair value
Balance-sheet strength
Altman Z 2.05 vs 2.38
Fundamental quality
Piotroski 5.00 vs 3.00 (of 9)
Growth + margins
Rule-of-40 15.80 vs 20.30
60-day momentum
-30.14% vs +3.01% price return
Market-cap liquidity
$171.1B vs $11.9B
Verdict
Across6categories,RDYtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onNVOorRDY
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.